Literature DB >> 26970302

MicroRNA-198 inhibited tumorous behaviors of human osteosarcoma through directly targeting ROCK1.

Shilian Zhang1, Yuehua Zhao2, Lijie Wang2.   

Abstract

Osteosarcoma is an aggressive primary sarcoma of bone and occurs mainly in adolescents and young adults. The prognosis of OS remains poor, and most of them will die due to local relapse or metastases. The discovery of microRNAs provides a new possibility for the early diagnosis and treatment of OS. Thus, the aim of this study was to explore the expression and functions of microRNA-198 (miR-198) in osteosarcoma. The expression levels of miR-198 were determined by qRT-PCR in osteosarcoma tissues and cell lines. Cell proliferation assays, migration and invasion assays were adopted to investigate the effects of miR-198 on tumorous behaviors of osteosarcoma cells. The results showed that miR-198 expression levels were lower in osteosarcoma tissues and cell lines. In addition, low miR-198 expression levels were correlated with TNM stage and distant metastasis. After miR-198 mimics transfection, cell proliferation, migration and invasion were significantly suppressed in the osteosarcoma cells. Furthermore, ROCK1 was identified as a novel direct target of miR-198 in osteosarcoma. These findings suggested that miR-198 may act not only as a novel prognostic marker, but also as a potential target for molecular therapy of osteosarcoma.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Growth; Metastasis; Osteosarcoma; ROCK1; microRNA-198

Mesh:

Substances:

Year:  2016        PMID: 26970302     DOI: 10.1016/j.bbrc.2016.03.040

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  miR-1297 regulates neural stem cell differentiation and viability through controlling Hes1 expression.

Authors:  Jiaolin Zheng; Dan Yi; Xiaodong Shi; Huaizhang Shi
Journal:  Cell Prolif       Date:  2017-05-02       Impact factor: 6.831

3.  MicroRNA-2682-3p inhibits osteosarcoma cell proliferation by targeting CCND2, MMP8 and Myd88.

Authors:  Fan Zhang; Yanjie Zhu; Guoxin Fan; Shuo Hu
Journal:  Oncol Lett       Date:  2018-06-27       Impact factor: 2.967

4.  The promising role and prognostic value of miR-198 in human diseases.

Authors:  Xiaoping Wang; Yanxia Zhu; Qiuli Xie
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

5.  MicroRNA-411 promoted the osteosarcoma progression by suppressing MTSS1 expression.

Authors:  Ning Xu; Weiliang Yang; Yang Liu; Feng Yan; Zhange Yu
Journal:  Environ Sci Pollut Res Int       Date:  2018-02-16       Impact factor: 4.223

6.  Hsa_circ_0010220 regulates miR-198/Syntaxin 6 axis to promote osteosarcoma progression.

Authors:  Zhaoan Lu; Chuanwen Wang; Xiaolong Lv; Wen Dai
Journal:  J Bone Oncol       Date:  2021-04-22       Impact factor: 4.072

7.  miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5.

Authors:  Chao Yuan; Zhenhong Su; Shengjie Liao; Duanzhuo Li; Zhiwen Zhou; Yawen Wang; Mingchun Quan; Lingling Zeng; Cai Lv; Chenyi Shen; Weida Gong; Jianfeng Wu; Xiaogang Chen; Wenbing Hu; Xu Lv; Wenxia Si; Xin Yu
Journal:  Cancer Cell Int       Date:  2021-07-21       Impact factor: 5.722

8.  MicroRNA-124 upregulation inhibits proliferation and invasion of osteosarcoma cells by targeting sphingosine kinase 1.

Authors:  Yan Zhou; Yanzhen Han; Zhitao Zhang; Zhe Shi; Liyuan Zhou; Xiaohong Liu; Xiaoyan Jia
Journal:  Hum Cell       Date:  2016-10-14       Impact factor: 4.374

9.  Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.

Authors:  Yue-Ya Liang; Jia-Cheng Huang; Rui-Xue Tang; Wen-Jie Chen; Peng Chen; Wei-Luan Cen; Ke Shi; Li Gao; Xiang Gao; An-Gui Liu; Xiao-Tong Peng; Gang Chen; Su-Ning Huang; Ye-Ying Fang; Yong-Yao Gu
Journal:  World J Surg Oncol       Date:  2018-02-02       Impact factor: 2.754

10.  Down-regulation of RPS9 Inhibits Osteosarcoma Cell Growth through Inactivation of MAPK Signaling Pathway.

Authors:  Dong-Dong Cheng; Bin Zhu; Shi-Jie Li; Ting Yuan; Qing-Cheng Yang; Cun-Yi Fan
Journal:  J Cancer       Date:  2017-08-22       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.